Schedule 13G ownership disclosure

Allena Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 018119107

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
269,836
Percent of class
0.5600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-21-000038
Form type
SC 13G/A
Filer
Allena Pharmaceuticals, Inc.
CIK
CIK 1624658
Filed
Jan 06, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub